Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
31255 | 125 | 24.6 | 52% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3080 | 1890 | ANTISECRETORY FACTOR//LOTEPREDNOL ETABONATE//METADOXINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BUDIPINE | Author keyword | 11 | 57% | 10% | 13 |
2 | 4 SUBSTITUTED ANILINES | Author keyword | 1 | 50% | 1% | 1 |
3 | LONG TERM ELECTROMYOGRAPHY | Author keyword | 1 | 50% | 1% | 1 |
4 | ORGANOMETAL CHEMISTRY | Author keyword | 1 | 50% | 1% | 1 |
5 | STYRYL DERIVATIVES | Author keyword | 1 | 50% | 1% | 1 |
6 | ANTI PARKINSONIAN | Author keyword | 0 | 33% | 1% | 1 |
7 | ANTITUMOUR PROPERTIES | Author keyword | 0 | 33% | 1% | 1 |
8 | ELECTROCHEMICAL REDOX POTENTIALS | Author keyword | 0 | 33% | 1% | 1 |
9 | FOOD AND ENVIRONMENTAL ANALYSIS | Author keyword | 0 | 33% | 1% | 1 |
10 | HETEROAROMATIC ALDEHYDES | Author keyword | 0 | 33% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ANTIPARKINSONIAN DRUG BUDIPINE | 5 | 63% | 4% | 5 |
2 | BUDIPINE | 1 | 50% | 2% | 2 |
3 | SILYL MODIFICATION | 1 | 50% | 2% | 2 |
4 | 4 THIAZOLIDONE | 0 | 33% | 1% | 1 |
5 | ISCHEMIC NEURONAL DEGENERATION | 0 | 11% | 1% | 1 |
6 | EVOKED ACETYLCHOLINE RELEASE | 0 | 10% | 1% | 1 |
7 | PERMEANT SIZE | 0 | 10% | 1% | 1 |
8 | DIAZASTILBENES | 0 | 100% | 1% | 1 |
9 | TREMORLYTIC ACTIVITY | 0 | 100% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Recent developments in the pharmacological treatment of Parkinson's disease | 2003 | 26 | 56 | 16% |
Iron oxide-based magnetic nanostructures bearing cytotoxic organosilicon molecules for drug delivery and therapy | 2010 | 3 | 28 | 21% |
Tremorlytic activity of budipine in Parkinson's disease | 1999 | 5 | 7 | 43% |
TREMORLYTIC ACTIVITY OF BUDIPINE - A QUANTITATIVE STUDY WITH LONG-TERM TREMOR RECORDINGS | 1995 | 14 | 5 | 60% |
PRODRUGS UTILIZING A REVERSIBLE SILYL LINKAGE | 1986 | 8 | 6 | 33% |
Therapy of Parkinson's disease .2. New therapeutic concepts for treating locomotor symptoms. | 1997 | 1 | 113 | 10% |
GLUTAMATERGIC MECHANISMS IN THE BRAIN IN MOVEMENT-DISORDERS AND SCHIZOPHRENIA | 1994 | 5 | 99 | 1% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UMR CPM 6226 | 0 | 33% | 0.8% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000270990 | L DOPA PRODRUGS//6 HYDROXYDOPAMINE 6 OHDA LESIONED RAT//PROXIMAGEN NEUROSCI PLC |
2 | 0.0000141570 | TELE STEREO EEG//ELECTROPHARMACOGRAM//CATEEM |
3 | 0.0000141512 | SILA DRUGS//MED PHARM CHIM BIOL NUTR//SILA SUBSTITUTION |
4 | 0.0000129252 | P450 ENZYME//ENZYMELESS BIOSENSORS//IRON TETRAPYRIDINOPORPHYRAZINE |
5 | 0.0000123927 | CGP 43487//L TRANS PYRROLIDINE 3 4 DICARBOXYLIC ACID//NEUROCYTOL RD29 |
6 | 0.0000112233 | POINT BY POINT ANALYSIS//OXASTEROIDS//KINETIC HYDROLYSIS |
7 | 0.0000083170 | RAT THORACIC AORTA RINGS//1 BENZYLIDENEAMINOPYRIDINIUM SALTS//2ND ORDER EFFECTS |
8 | 0.0000080952 | ACETYLTRYPTOPHAN//DERIVATISATION GC//CONCENTRATED ALBUMIN |
9 | 0.0000079772 | NIPECOTAMIDES//ALPHA THROMBIN BINDING//CYTOSOLIC CA2 INCREASE |
10 | 0.0000073916 | 3 4 BISTRIMETHYLSILYLFURAN//3 4 DISUBSTITUTED FURANS//KAHWEOFURAN |